CPHI China 2026 Concludes Successfully in Shanghai | Chenghui Pharmaceutical Completed Fruitful Exhibition Journey
2026-06-26
The three-day CPHI China 2026 officially came to a successful close at the Shanghai New International Expo Centre. As a premier annual e...
View details >
Join Chenghui Pharmaceutical at CPHI China 2026 | Booth W1D26
2026-06-09
Shandong Chenghui Pharmaceutical Group Co., Ltd., together with its core production base — Shandong Chenghui Shuangda Pharmaceutical Co., Ltd., will ...
Join Us at CPHI Japan 2026 | Booth 1C-08
2026-04-15
Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. will participate in CPHI Japan 2026 in Tokyo, Japan, from April 21 to 23, 2026, at Booth 1C-08. ...
News Flash: Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. Achieves Major Milestone with Approval of Self-Developed Apalutamide API
2026-03-20
Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. proudly announces that its self-developed Active Pharmaceutical Ingredient (API), Apalutamid...
Shandong Chenghui Pharmaceuticals: Warmth of the Season, Prosperous Year of the Horse – Spring Festival Benefits Convey Gratitude for Every Dedication
2026-02-26
To All Colleagues and Partners Time surges forward, and our journey of striving never pauses. As we bid farewell to the o...
New Year Greeting from Shandong Chenghui Pharma
2025-12-31
As the year 2026 approaches, we at Shandong Chenghui Pharmaceutical extend our warmest wishes to our global partners and clients. May the New Year...
Global Recognition: Prilocaine CEP Certified by EDQM
2025-12-26
On December 19, 2025, our company reached a pivotal milestone in international pharmaceutical development, as the European Pharmacopoeia Suitability ...
Corporate News: Successful Approval of CEP Certificate for Lidocaine Hydrochloride API by EDQM
2025-11-19
On November 10, 2025, our company successfully obtained approval for the European CEP registration of our active pharmaceutical ingredient (API), Lido...
View more
Report of the 19th National Congress for the good things about pharmaceutical industry
2018-09-13
The 19th National Congress of the Communist Party of China officially opened. At the meeting, the report entitled "The Great Victory of....
Conference on the Comprehensive and Deep Restructuring of the Central Committee: Expanding the Coverage of the Medical Insurance System
Xi Jinping, General Secretary of the CPC Central Committee, President of the State Council, Chairman of the Central Military Commission....
Multivariate payment of health insurance will be fully implemented，payment by disease species is the direction of reform
The General Office of the State Council recently issued the Guiding Opinions on Further Deepening the Reform of the Payment Method for ....
Copyright 2018 Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. All Rights Reserved Lu ICP 18055647
